Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
BörsenkürzelCSBR
Name des UnternehmensChampions Oncology Inc
IPO-datumNov 30, 1988
CEODr. Ronnie Morris, M.D.
Anzahl der mitarbeiter213
WertpapierartOrdinary Share
GeschäftsjahresendeNov 30
AddresseOne University Plaza,
StadtHACKENSACK
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl07601
Telefon12018088400
Websitehttps://championsoncology.com
BörsenkürzelCSBR
IPO-datumNov 30, 1988
CEODr. Ronnie Morris, M.D.
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten